2023-07-24 16:47:46 ET
- NeuroOne Medical Technologies Corporation ( NASDAQ: NMTC ) falls 29% in extended trading after announcing proposed public offering of its common stock.
- All of the shares of common stock to be sold in the proposed offering will be sold by the company.
- In addition, NeuroOne intends to grant the underwriter a 30-day option to purchase up to additional 15% of the shares of its common stock sold in the offering.
- The company intends to use the proceeds to support the commercial launch of the EVO sEEG electrode with Zimmer Biomet and complete the design of a novel drug delivery electrode, among other general corporate purposes.
- Source: Press Release
For further details see:
NeuroOne Medical Technologies falls after announcing proposed public offering of common stock